Publications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (40)

2024

  1. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

    Journal of Clinical Medicine, Vol. 13, Núm. 4

  2. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology

2023

  1. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  2. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  3. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  4. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  5. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

    Biomedicines, Vol. 11, Núm. 2

  6. Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  7. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

2022

  1. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1

  2. Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO

    ERJ Open Research, Vol. 8, Núm. 3

  3. Determinants in the Underdiagnosis of COPD in Spain—CONOCEPOC Study

    Journal of Clinical Medicine, Vol. 11, Núm. 9

  4. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  5. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis

    Journal of Clinical Medicine, Vol. 11, Núm. 14

  6. Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study

    Open Forum Infectious Diseases, Vol. 9, Núm. 4

  7. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

  8. Testing for Vitamin D in High-Risk COPD in Outpatient Clinics in Spain: A Cross-Sectional Analysis of the VITADEPOC Study

    Journal of Clinical Medicine, Vol. 11, Núm. 5

2021

  1. Assessing the usefulness of the prevexair smartphone application in the follow-up high-risk patients with COPD

    International Journal of COPD, Vol. 16, pp. 53-65

  2. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27

  3. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36